335 related articles for article (PubMed ID: 33005486)
21. Emergency SARS-CoV-2 Variants of Concern: Novel Multiplex Real-Time RT-PCR Assay for Rapid Detection and Surveillance.
Chung HY; Jian MJ; Chang CK; Lin JC; Yeh KM; Chen CW; Hsieh SS; Hung KS; Tang SH; Perng CL; Chang FY; Wang CH; Shang HS
Microbiol Spectr; 2022 Feb; 10(1):e0251321. PubMed ID: 35196812
[TBL] [Abstract][Full Text] [Related]
22. Spike Protein Cleavage-Activation in the Context of the SARS-CoV-2 P681R Mutation: an Analysis from Its First Appearance in Lineage A.23.1 Identified in Uganda.
Lubinski B; Frazier LE; Phan MVT; Bugembe DL; Cunningham JL; Tang T; Daniel S; Cotten M; Jaimes JA; Whittaker GR
Microbiol Spectr; 2022 Aug; 10(4):e0151422. PubMed ID: 35766497
[TBL] [Abstract][Full Text] [Related]
23. Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity.
Essalmani R; Jain J; Susan-Resiga D; Andréo U; Evagelidis A; Derbali RM; Huynh DN; Dallaire F; Laporte M; Delpal A; Sutto-Ortiz P; Coutard B; Mapa C; Wilcoxen K; Decroly E; Nq Pham T; Cohen ÉA; Seidah NG
J Virol; 2022 Apr; 96(8):e0012822. PubMed ID: 35343766
[TBL] [Abstract][Full Text] [Related]
24. SARS-CoV-2 Spike Protein Extrapolation for COVID Diagnosis and Vaccine Development.
Malik YS; Kumar P; Ansari MI; Hemida MG; El Zowalaty ME; Abdel-Moneim AS; Ganesh B; Salajegheh S; Natesan S; Sircar S; Safdar M; Vinodhkumar OR; Duarte PM; Patel SK; Klein J; Rahimi P; Dhama K
Front Mol Biosci; 2021; 8():607886. PubMed ID: 34395515
[TBL] [Abstract][Full Text] [Related]
25. Proteolytic cleavage of the SARS-CoV-2 spike protein and the role of the novel S1/S2 site.
Jaimes JA; Millet JK; Whittaker GR
SSRN; 2020 May; ():3581359. PubMed ID: 32714113
[TBL] [Abstract][Full Text] [Related]
26. Coronavirus Disease Pandemic (COVID-19): Challenges and a Global Perspective.
Malik YS; Kumar N; Sircar S; Kaushik R; Bhat S; Dhama K; Gupta P; Goyal K; Singh MP; Ghoshal U; El Zowalaty ME; O R V; Yatoo MI; Tiwari R; Pathak M; Patel SK; Sah R; Rodriguez-Morales AJ; Ganesh B; Kumar P; Singh RK
Pathogens; 2020 Jun; 9(7):. PubMed ID: 32605194
[TBL] [Abstract][Full Text] [Related]
27. Proteolytic Activation of SARS-CoV-2 Spike at the S1/S2 Boundary: Potential Role of Proteases beyond Furin.
Tang T; Jaimes JA; Bidon MK; Straus MR; Daniel S; Whittaker GR
ACS Infect Dis; 2021 Feb; 7(2):264-272. PubMed ID: 33432808
[TBL] [Abstract][Full Text] [Related]
28. The SARS-CoV-2 Transcriptome and the Dynamics of the S Gene Furin Cleavage Site in Primary Human Airway Epithelia.
Zou W; Xiong M; Hao S; Zhang EY; Baumlin N; Kim MD; Salathe M; Yan Z; Qiu J
mBio; 2021 May; 12(3):. PubMed ID: 33975939
[TBL] [Abstract][Full Text] [Related]
29. Current Therapeutics for COVID-19, What We Know about the Molecular Mechanism and Efficacy of Treatments for This Novel Virus.
Narayanan D; Parimon T
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887042
[TBL] [Abstract][Full Text] [Related]
30. COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses.
Shereen MA; Khan S; Kazmi A; Bashir N; Siddique R
J Adv Res; 2020 Jul; 24():91-98. PubMed ID: 32257431
[TBL] [Abstract][Full Text] [Related]
31. SARS-CoV-2 pandemics: An update of CRISPR in diagnosis and host-virus interaction studies.
Tang WF; Tran AT; Wang LY; Horng JT
Biomed J; 2023 Apr; 46(2):100587. PubMed ID: 36849044
[TBL] [Abstract][Full Text] [Related]
32. A Feasible Alternative Strategy Targeting Furin Disrupts SARS-CoV-2 Infection Cycle.
Mondal T; Shivange G; Habieb A; Tushir-Singh J
Microbiol Spectr; 2022 Feb; 10(1):e0236421. PubMed ID: 35138160
[TBL] [Abstract][Full Text] [Related]
33. Origin and Structural Biology of Novel Coronavirus (SARS-CoV-2).
Mallick R; Duttaroy AK
Adv Exp Med Biol; 2021; 1352():1-13. PubMed ID: 35132591
[TBL] [Abstract][Full Text] [Related]
34. A novel bat coronavirus with a polybasic furin-like cleavage site.
Zhu W; Huang Y; Gong J; Dong L; Yu X; Chen H; Li D; Zhou L; Yang J; Lu S
Virol Sin; 2023 Jun; 38(3):344-350. PubMed ID: 37141989
[TBL] [Abstract][Full Text] [Related]
35. COVID-19 CG enables SARS-CoV-2 mutation and lineage tracking by locations and dates of interest.
Chen AT; Altschuler K; Zhan SH; Chan YA; Deverman BE
Elife; 2021 Feb; 10():. PubMed ID: 33620031
[TBL] [Abstract][Full Text] [Related]
36. Proteolytic activation of SARS-CoV-2 spike protein.
Takeda M
Microbiol Immunol; 2022 Jan; 66(1):15-23. PubMed ID: 34561887
[TBL] [Abstract][Full Text] [Related]
37. Genome-wide bioinformatics analysis of human protease capacity for proteolytic cleavage of the SARS-CoV-2 spike glycoprotein.
Matveev EV; Ponomarev GV; Kazanov MD
Microbiol Spectr; 2024 Feb; 12(2):e0353023. PubMed ID: 38189333
[TBL] [Abstract][Full Text] [Related]
38. Molecular Insights of SARS-CoV-2 Infection and Molecular Treatments.
Abdurrahman L; Fang X; Zhang Y
Curr Mol Med; 2022; 22(7):621-639. PubMed ID: 34645374
[TBL] [Abstract][Full Text] [Related]
39. SARS-CoV-2 strategically mimics proteolytic activation of human ENaC.
Anand P; Puranik A; Aravamudan M; Venkatakrishnan AJ; Soundararajan V
Elife; 2020 May; 9():. PubMed ID: 32452762
[TBL] [Abstract][Full Text] [Related]
40. Fighting COVID-19: A quick review of diagnoses, therapies, and vaccines.
Shih HI; Wu CJ; Tu YF; Chi CY
Biomed J; 2020 Aug; 43(4):341-354. PubMed ID: 32532623
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
